Drug Interactions Between Lorazepam and Sertraline
The combination of lorazepam and sertraline can be used together, but requires careful monitoring for additive CNS depression (sedation, drowsiness, respiratory depression) and, rarely, serotonin syndrome. The primary concern is pharmacodynamic interaction causing enhanced sedation rather than a pharmacokinetic interaction.
Key Interaction Mechanisms
CNS Depression (Primary Concern)
Lorazepam, as a benzodiazepine, produces additive CNS depression when combined with other CNS depressants including antidepressants like sertraline 1. This manifests as:
- Increased sedation and drowsiness
- Respiratory depression risk (particularly in elderly, those with COPD, or at higher doses)
- Increased fall risk
- Cognitive impairment
- Paradoxical agitation (occurs in ~10% of benzodiazepine-treated patients) 2
The FDA label for lorazepam explicitly warns that injectable benzodiazepines produce additive CNS depression when administered with antidepressants 1. While this specifically references injectable formulations, the principle applies to oral administration as well.
Serotonin Syndrome (Rare but Serious)
Although uncommon, serotonin syndrome can occur even with sertraline monotherapy 3, 4, and benzodiazepines like lorazepam are sometimes used as treatment for serotonin syndrome symptoms 3, 4. However, the combination theoretically could complicate recognition of early serotonin syndrome due to overlapping sedative effects.
Clinical Management Recommendations
Dosing Adjustments
Start with lower doses of lorazepam when co-administered with sertraline, particularly in:
No pharmacokinetic interaction exists requiring sertraline dose adjustment—sertraline does not significantly inhibit the enzymes metabolizing lorazepam 6
Monitoring Parameters
Monitor patients for:
- Excessive sedation or lethargy (most common)
- Respiratory rate and depth (especially first 24-48 hours)
- Fall risk assessment in ambulatory patients
- Paradoxical agitation or behavioral changes
- Signs of serotonin syndrome: neuromuscular excitability (hyperreflexia, clonus), autonomic instability, altered mental status 3, 4
Special Populations
Elderly patients warrant particular caution 7, 8:
- More susceptible to benzodiazepine adverse effects
- Higher risk of falls, delirium, and respiratory depression
- Consider non-benzodiazepine alternatives when possible
- If benzodiazepines necessary, use lowest effective dose for shortest duration
Common Clinical Scenarios
Acute Anxiety with Depression
When treating acute anxiety in a patient on sertraline:
- Lorazepam 0.5-1 mg PRN is reasonable for short-term use
- Limit to 2-4 weeks to avoid tolerance and dependence 2
- Taper and discontinue once sertraline's anxiolytic effects emerge (typically 2-4 weeks)
Agitation Management
For severe agitation in patients on sertraline:
- Lorazepam can be used but with dose reduction (0.25-0.5 mg in elderly/frail) 5
- Monitor closely for oversedation
- Consider antipsychotic alternatives if prolonged treatment needed
Important Caveats
Avoid chronic co-administration: Regular benzodiazepine use can lead to tolerance, addiction, depression, and cognitive impairment 2. The combination should ideally be time-limited.
No significant pharmacokinetic interaction: Unlike some SSRIs (fluoxetine, fluvoxamine), sertraline does not significantly inhibit CYP enzymes that metabolize benzodiazepines 6. Lorazepam undergoes glucuronide conjugation rather than CYP metabolism, making pharmacokinetic interactions with sertraline unlikely 8.
Therapeutic use exists: The combination is sometimes intentionally prescribed—lorazepam for acute anxiety/agitation while awaiting sertraline's therapeutic effect, or lorazepam as treatment for sertraline-induced serotonin syndrome 3, 4.
Document rationale: When prescribing this combination, document the clinical indication, planned duration, and monitoring plan to ensure appropriate use and facilitate safe discontinuation.